Advertisement

Drugs

, Volume 69, Issue 4, pp 393–406 | Cite as

Medication Therapy Management Services

Definitions and Outcomes
  • Annette N. Pellegrino
  • Michelle T. Martin
  • Jessica J. Tilton
  • Daniel R. TouchetteEmail author
Current Opinion

Abstract

In the US, the Medicare Modernization Act of 2003 required that Medicare Part D insurers provide medication therapy management (MTM) services (MTMS) to selected beneficiaries, with the goals of providing education, improving adherence, or detecting adverse drug events and medication misuse. These broad goals and variety in MTM programmes available make assessment of these programmes difficult. The objectives of this article are to review the definitions of MTMS proposed by various stakeholders, and to summarize and evaluate the outcomes of MTMS consistent with those that may be offered in Medicare Part D or reimbursed by State Medicaid programmes.

MTM programmes are approved by the Centers for Medicare and Medicaid Services (CMS). Pharmacy, medical and insurance organizations have provided guidelines and definitions for MTM programmes, distinguishing them from other types of community pharmacy activities. MTM has been distinguished from disease state management because of the focus on medications and multiple conditions. It differs from patient counselling because it is delivered independent of dispensing and involves collaboration with patients and providers. There is no consensus on the recommended mode of delivery (i.e. face-to-face or by telephone) for MTM.

A MEDLINE search was conducted to identify articles published after 2000 using the search terms ‘medication therapy management’ and ‘medication management’. Studies with outcomes evaluating community-based programmes consistent with MTMS, regardless of MTMS reimbursement source, were included in the review. Seven publications describing four MTMS were identified. For each of the identified articles, we describe the study design, service setting, inclusion criteria and outcomes. An additional three surveys describing multiple MTMS were identified and are summarized. Finally, ongoing efforts by CMS to evaluate the success of MTMS in the US are described.

To date, there are limited outcomes available for MTMS. The wide variety of MTMS offered means that evaluations of individual programmes are necessary. Despite the potential benefits of MTMS, there are numerous challenges to providing MTMS, including reimbursement, justification of the service and stakeholder acceptance of the services. There remains a need for adequately funded, prospective, controlled studies of MTM programmes using strong designs to advance our knowledge of the effectiveness of various interventions and methods of delivery, and for naturalistic studies assessing the impact of CMS approved MTM programmes.

Keywords

Community Pharmacy Pharmaceutical Care Medicare Part Clinical Pharmacy Service Medication Therapy Management 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52(8): 1349–54PubMedCrossRefGoogle Scholar
  2. 2.
    Hanlon JT, Fillenbaum GG, Schmader KE, et al. Inappropriate drug use among community-dwelling elderly. Pharmacotherapy 2000; 20(5): 575–82PubMedCrossRefGoogle Scholar
  3. 3.
    Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63(2): 187–95PubMedCrossRefGoogle Scholar
  4. 4.
    Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288(4): 455–61PubMedCrossRefGoogle Scholar
  5. 5.
    Cramer J, Rosenheck R, Kirk G, et al. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 2003; 6(5): 566–73PubMedCrossRefGoogle Scholar
  6. 6.
    Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288(4): 462–7PubMedCrossRefGoogle Scholar
  7. 7.
    Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002; 288(22): 2880–3PubMedCrossRefGoogle Scholar
  8. 8.
    Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60(7): 657–65PubMedGoogle Scholar
  9. 9.
    The Medicare Prescription Drug, Improvement, and Modernization Act, HR 1/ Pub. L. No. 108-173, 2003 Dec 8 [online]. Available from URL: http://www.cms.hhs.gov/MMAUpdate/downloads/PL108-173summary.pdf [Accessed 2009 Mar 2]
  10. 10.
    Department of Health and Human Services — Centers for Medicare and Medicaid Services. 42 CFR Parts 400,403,411, 417, and 423 [CMS-4068-F]-Final Rule, Medicare program; Medicare prescription drug benefit, 2005 Jan 28 [online]. Available from URL: http://www.cms.hhs.gov/quarterlyproviderupdates/downloads/CMS4068F.PDF [Accessed 2006 Jul 12]
  11. 11.
    Smith SR, Clancy CM. Medication therapy management programs: forming a new cornerstone for quality and safety in medicare. Am J Med Qual 2006; 21(4): 276–9PubMedCrossRefGoogle Scholar
  12. 12.
    Touchette DR, Burns AL, Bough MA, et al. Survey of medication therapy management programs under Medicare part D. J Am Pharm Assoc (Wash DC) 2006; 46(6): 683–91Google Scholar
  13. 13.
    Boyd ST, Boyd LC, Zillich AJ. Medication therapy management survey of the prescription drug plans. J Am Pharm Assoc (2003) 2006; 46(6): 692–9CrossRefGoogle Scholar
  14. 14.
    Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc (2003) 2005; 45(5): 566–72CrossRefGoogle Scholar
  15. 15.
    Anonymous. Summary of the executive sessions on medication therapy management programs: Bethesda, Maryland, June 14 and August 18, 2004. J Manag Care Pharm 2005; 11 (2): 179-86Google Scholar
  16. 16.
    American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 1.0). J Am Pharm Assoc (2003) 2005; 45(5): 573–9CrossRefGoogle Scholar
  17. 17.
    American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc (2003) 2008; 48(3): 341–53CrossRefGoogle Scholar
  18. 18.
    Sound medication therapy management programs. J Manag Care Pharm 2006; 12 (3 Suppl.): S2–13Google Scholar
  19. 19.
    Anonymous. Sound medication therapy management programs, version 2.0 with validation study. J Manag Care Pharm 2008; 14 (1 Suppl. B): S2-44Google Scholar
  20. 20.
    McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003) 2007; 47(5): 620–8CrossRefGoogle Scholar
  21. 21.
    Omnibus Budget Reconciliation Act, HR 5835 (1990) [online]. Available from URL: http://thomas.loc.gov/ [Accessed 2009 Mar 2]
  22. 22.
    Disease Management Association of America. DMAA definition of disease management [online]. Available from URL: http://www.dmaa.org/dm_definition.asp [Accessed 2009 Mar 2]
  23. 23.
    Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001; 24(3): 561–87PubMedCrossRefGoogle Scholar
  24. 24.
    Norris SL, Lau J, Smith SJ, et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002; 25(7): 1159–71PubMedCrossRefGoogle Scholar
  25. 25.
    Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41(11): 1770–81Google Scholar
  26. 26.
    Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother 2007; 41(10): 1569–82Google Scholar
  27. 27.
    Machado M, Nassor N, Bajcar JM, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother 2008; 42(9): 1195–207Google Scholar
  28. 28.
    Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev 2000; (3): CD000336Google Scholar
  29. 29.
    Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy 2003; 23(1): 113–32PubMedCrossRefGoogle Scholar
  30. 30.
    Schumock GT, Meek PD, Ploetz PA, et al. Economic evaluations of clinical pharmacy services: 1988–1995. The Publications Committee of the American College of Clinical Pharmacy. Pharmacotherapy 1996; 16(6): 1188–208Google Scholar
  31. 31.
    Lipton HL, Byrns PJ, Soumerai SB, et al. Pharmacists as agents of change for rational drug therapy. Int J Technol Assess Health Care 1995; 11(3): 485–508PubMedCrossRefGoogle Scholar
  32. 32.
    Carter BL, Helling DK. Ambulatory care pharmacy services: has the agenda changed? Ann Pharmacother 2000; 34(6): 772–87PubMedCrossRefGoogle Scholar
  33. 33.
    Kozma CM, Reeder CE, Schulz RM. Economic pharmacists and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993; 15(6): 1121–32Google Scholar
  34. 34.
    Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc (2003) 2004; 44(3): 337–49CrossRefGoogle Scholar
  35. 35.
    Doucette WR, McDonough RP, Klepser D, et al. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005; 27(7): 1104–11PubMedCrossRefGoogle Scholar
  36. 36.
    Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–24PubMedCrossRefGoogle Scholar
  37. 37.
    Smith SR, Catellier DJ, Conlisk EA, et al. Effect on health outcomes of a community-based medication therapy management program for seniors with limited incomes. Am J Health Syst Pharm 2006; 63(4): 372–9PubMedCrossRefGoogle Scholar
  38. 38.
    Christensen DB, Roth M, Trygstad T, et al. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan. J Am Pharm Assoc (2003) 2007; 47(4): 471–83CrossRefGoogle Scholar
  39. 39.
    Isetts BJ, Schondelmeyer SW, Heaton AH, et al. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Res Social Adm Pharm 2006; 2(1): 129–42PubMedCrossRefGoogle Scholar
  40. 40.
    Isetts BJ, Brown LM, Schondelmeyer SW, et al. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 2003; 163(15): 1813–20PubMedCrossRefGoogle Scholar
  41. 41.
    Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc (2003) 2008; 48(2): 203–11CrossRefGoogle Scholar
  42. 42.
    Hansen RA, Roth MT, Brouwer ES, et al. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand. J Am Pharm Assoc (2003) 2006; 46(6): 700–6CrossRefGoogle Scholar
  43. 43.
    Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 1): provider perspectives in 2007. J Am Pharm Assoc (2003) 2008; 48(3): 354–63CrossRefGoogle Scholar
  44. 44.
    Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007. J Am Pharm Assoc (2003) 2008; 48(4): 478–86CrossRefGoogle Scholar
  45. 45.
    Tice B. What's in store for MTM? Chain Drug Rev 2008 Aug 18 [online]. Available from URL: http://findarticles.com/p/articles/mi_hb3007/is_14_30/ai_n28568002 [Accessed 2009 Mar 2]
  46. 46.
    Department of Health and Human Services — Centers for Medicare and Medicaid Services. Medicare Rx update: April 19 2006. Pharmacy quality alliance…now a reality [online]. Available from URL: http://www.cms.hhs.gov/Pharmacy/downloads/update041906.pdf [Accessed 2009 Mar 2]
  47. 47.
    Pharmacy Quality Alliance. Executive overview of the 2008 activities of the PQA cluster group on medication therapy management [online]. Available from URL: http://www.pqaalliance.org [Accessed 2008 Mar 10]
  48. 48.
    Pharmacy Quality Alliance. PQA announces official launch of demonstration projects [media release]. 2008 Jul 9 [online]Available from URL: http://www.pqaalliance.org/files/PQALaunchofDemoProjectsJuly2008.pdf [Accessed 2009 Mar 2]
  49. 49.
    Pharmacy Quality Alliance. PQA call for proposals: demonstration projects (phase 1) [online]. Available from URL: http://www.pqaalliance.org/files/PQA_CEDISSEMINATION_RFP.pdf [Accessed 2009 Mar 2]
  50. 50.
    Institute of Medicine. To err is human: building a safer health system. Washington, DC: Institute of Medicine, 2000Google Scholar
  51. 51.
    Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: Institute of Medicine, 2001Google Scholar
  52. 52.
    Kairuz T, Bye L, Birdsall R, et al. Identifying compliance issues with prescription medicines among older people: a pilot study. Drugs Aging 2008; 25(2): 153–62PubMedCrossRefGoogle Scholar
  53. 53.
    Lowe CJ, Raynor DK, Purvis J, et al. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50(2): 172–5PubMedCrossRefGoogle Scholar
  54. 54.
    Zermansky AG, Petty DR, Raynor DK, et al. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial. Health Technol Assess 2002; 6(20): 1–86PubMedGoogle Scholar
  55. 55.
    Forster AJ, Clark HD, Menard A, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004; 170(3): 345–9PubMedGoogle Scholar
  56. 56.
    Alvarez-Risco A, van Mil JW. Pharmaceutical care in community pharmacies: practice and research in Peru. Ann Pharmacother 2007; 41(12): 2032–7PubMedCrossRefGoogle Scholar
  57. 57.
    Bell JS, Vaananen M, Ovaskainen H, et al. Providing patient care in community pharmacies: practice and research in Finland. Ann Pharmacother 2007; 41(6): 1039–46PubMedCrossRefGoogle Scholar
  58. 58.
    Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother 2005; 39(11): 1911–7PubMedCrossRefGoogle Scholar
  59. 59.
    Costa S, Santos C, Silveira J. Community pharmacy services in Portugal. Ann Pharmacother 2006; 40(12): 2228–34PubMedCrossRefGoogle Scholar
  60. 60.
    Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother 2006; 40(4): 729–35PubMedCrossRefGoogle Scholar
  61. 61.
    Gastelurrutia MA, Faus MJ, Fernandez-Llimos F. Providing patient care in community pharmacies in Spain. Ann Pharmacother 2005; 39(12): 2105–10PubMedCrossRefGoogle Scholar
  62. 62.
    Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother 2006; 40(3): 512–7PubMedCrossRefGoogle Scholar
  63. 63.
    Herborg H, Sorensen EW, Frokjaer B. Pharmaceutical care in community pharmacies: practice and research in Denmark. Ann Pharmacother 2007; 41(4): 681–9PubMedCrossRefGoogle Scholar
  64. 64.
    Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother 2005; 39(9): 1527–33PubMedCrossRefGoogle Scholar
  65. 65.
    Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother 2007; 41(5): 861–8PubMedCrossRefGoogle Scholar
  66. 66.
    van Mil JW. Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother 2005; 39(10): 1720–5PubMedCrossRefGoogle Scholar
  67. 67.
    Volmer D, Vendla K, Vetka A, et al. Pharmaceutical care in community pharmacies: practice and research in Estonia. Ann Pharmacother 2008; 42(7): 1104–11PubMedCrossRefGoogle Scholar
  68. 68.
    Westerlund LT, Bjork HT. Pharmaceutical care incommunity pharmacies: practice and research in Sweden. Ann Pharmacother 2006; 40(6): 1162–9PubMedCrossRefGoogle Scholar
  69. 69.
    Yamamura S, Yamamoto N, Oide S, et al. Current state of community pharmacy in Japan: practice, research, and future opportunities or challenges. Ann Pharmacother 2006; 40(11): 2008–14PubMedCrossRefGoogle Scholar
  70. 70.
    Cranor CW, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003; 43(2): 173–84CrossRefGoogle Scholar
  71. 71.
    Pharmacist Services Technical Advisory Coalition [online]. Available from URL: http://www.pstac.org/aboutus/profsvc.html [Accessed 2007 Dec 22]
  72. 72.
    Brusig E, Davies W. PSTAC survey in 2006 was instrumental in obtaining permanent (category I) CPT codes for MTM services performed by pharmacists. J Manag Care Pharm 2008; 14(1): 86–7PubMedGoogle Scholar
  73. 73.
    Isetts BJ, Buffington DE. CPT code-change proposal: national data on pharmacists' medication therapy management services. Am J Health Syst Pharm 2007; 64(15): 1642–6PubMedCrossRefGoogle Scholar
  74. 74.
    Farmer AP, Legare F, Turcot L, et al. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2008; (3): CD004398Google Scholar
  75. 75.
    Moczygemba LR, Barner JC, Gabrillo ER, et al. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries. Am J Health Syst Pharm 2008; 65(17): 1655–60PubMedCrossRefGoogle Scholar
  76. 76.
    Currell R, Urquhart C, Wainwright P, et al. Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; (2): CD002098Google Scholar
  77. 77.
    Masica AL, Touchette DR, Dolor R, et al. Evaluation of a medication therapy management program on patient safety in Medicare beneficiaries at high risk of adverse drug events: study methods. In: Henriksen K, Battles JB, Keyes MA, et al., editors. Advances in patient safety. Vol. 4: technology and medication safety (AHRQ 08-0034-4). Rockville (MD): AHRQ, 2008 [online]. Available from URL: http://www.ahrq.gov/qual/advances2/#v4 [Accessed 2009 Mar 2]
  78. 78.
    Kliethermes MA, Schullo-Feulner AM, Tilton J, et al. Model for medication therapy management in a university clinic. Am J Health Syst Pharm 2008; 65(9): 844–56PubMedCrossRefGoogle Scholar
  79. 79.
    McMahan R. Operationalizing MTM. through the use of health information technology. J Manag Care Pharm 2008; 14(2Suppl.): S18–21PubMedGoogle Scholar
  80. 80.
    Herbert KE, Urmie JM, Newland BA, et al. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm 2006; 2(3): 299–314PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2009

Authors and Affiliations

  • Annette N. Pellegrino
    • 1
  • Michelle T. Martin
    • 1
  • Jessica J. Tilton
    • 1
  • Daniel R. Touchette
    • 1
    • 2
    Email author
  1. 1.Department of Pharmacy PracticeUniversity of Illinois at Chicago, College of PharmacyChicagoUSA
  2. 2.Center for Pharmacoeconomic Research, Core FacultyUniversity of Illinois at Chicago College of PharmacyChicagoUSA

Personalised recommendations